Skip to main content

Table 1 Patient-, tumor- and treatment-related characteristics

From: Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study

Characteristics No. %
No. of patients 68 100
Age (years)   
  Median 63
  Range 40–75
Gender   
  Male 58 85.3
  Female 10 14.7
Performance status   
  KPS 70-80 52 76.5
  KPS 90-100 16 23.5
AJCC TNM stage   
  Stage IIa 10 14.7
  Stage IIb 4 5.9
  Stage III 32 47.1
  Stage IVa 22 32.3
Tumor length (cm)   
  Median 5.0
  Range 2.0–11.5
Tumor location   
  Cervical 8 11.8
  Upper-thoracic 24 35.3
  Mid-thoracic 27 39.7
  Lower-thoracic 9 13.2
*Regimens   
  5-fluorouracil 20 29.4
  Capecitabine 12 17.5
  Pemetrexed 32 47.1
  1. * Others treated with cisplatin plus vinorelbineis (1), gemcitabine (1), and docetaxel (2).